| Scientific Name | Adalimumab |
|---|---|
| Brand Name | Humira |
| Risk | Safety information about risks of Tuberculosis (TB), Malignancies, Demyelinating disorders (including multiple sclerosis [MS], Guillain-Barré syndrome [GBS] and optic neuritis [ON]), BCG disease following live BCG vaccination in infants with in utero exposure to Humira. |
| Safety Communication for Healthcare Professionals |
